1087 related items for PubMed ID: 11113839
1. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
Léger J, Reynaud R, Czernichow P.
J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
[Abstract] [Full Text] [Related]
2. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
Massart F, Federico G, Harrell JC, Saggese G.
Neuroendocrinology; 2009 Dec; 90(3):307-14. PubMed ID: 19641297
[Abstract] [Full Text] [Related]
3. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone release hormone (D-Tryp6-GnRH) in monthly injections. Its possible use in normal puberty.
Marcondes JA, Abujamra AC, Minanni SL, Mendonca BB, Nery M, Lerario AC, Pereira MA, Abelin N, Wajchenberg BL.
Horm Metab Res; 1993 Feb; 25(2):105-9. PubMed ID: 8458605
[Abstract] [Full Text] [Related]
4. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone.
Mul D, Oostdijk W, Waelkens JJ, Drop SL.
Clin Endocrinol (Oxf); 2005 Aug; 63(2):185-90. PubMed ID: 16060912
[Abstract] [Full Text] [Related]
5. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DC, Crigler JF, Crowley WF.
N Engl J Med; 1983 Nov 24; 309(21):1286-90. PubMed ID: 6415479
[Abstract] [Full Text] [Related]
6. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
Chen SK, Fan X, Tang Q.
Zhongguo Dang Dai Er Ke Za Zhi; 2009 May 24; 11(5):374-6. PubMed ID: 19470261
[Abstract] [Full Text] [Related]
7. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
Styne DM, Harris DA, Egli CA, Conte FA, Kaplan SL, Rivier J, Vale W, Grumbach MM.
J Clin Endocrinol Metab; 1985 Jul 24; 61(1):142-51. PubMed ID: 3923027
[Abstract] [Full Text] [Related]
8. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF, McNeill E, Young D, Donaldson MD.
Clin Endocrinol (Oxf); 2004 Nov 24; 61(5):626-34. PubMed ID: 15521967
[Abstract] [Full Text] [Related]
9. Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls.
Houk CP, Kunselman AR, Lee PA.
Pediatrics; 2009 Jun 24; 123(6):e1059-63. PubMed ID: 19482738
[Abstract] [Full Text] [Related]
10. [Clinical application of simplified gonadotropin releasing hormone stimulating test in management of female isosexual precocious puberty].
Zhang YW, Ma LK, Zhou J, Zhang DY.
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun 24; 39(6):378-81. PubMed ID: 15312320
[Abstract] [Full Text] [Related]
11. Final adult height in "early normal pubertal girls" treated with gonadotropin releasing hormone agonists.
Wacharasindhu S, Srivuthana S, Aroonparkmongkol S, Supornsilchai V, Hiranrat P, Yodvisitsak V.
J Med Assoc Thai; 2003 Jun 24; 86 Suppl 2():S170-3. PubMed ID: 12929985
[Abstract] [Full Text] [Related]
12. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
Kohn B, Julius JR, Blethen SL.
Pediatrics; 1999 Oct 24; 104(4 Pt 2):1014-8. PubMed ID: 10506254
[Abstract] [Full Text] [Related]
13. Growth, bone maturation and height prediction after three years of therapy with the slow release GnRH-agonist Decapeptyl-Depot in children with central precocious puberty.
Hümmelink R, Oostdijk W, Partsch CJ, Odink RJ, Drop SL, Sippell WG.
Horm Metab Res; 1992 Mar 24; 24(3):122-6. PubMed ID: 1533604
[Abstract] [Full Text] [Related]
14. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
Ságodi L, Sólyom E, Lombay B, Almási A, Vámosi I.
Orv Hetil; 2012 Mar 18; 153(11):418-24. PubMed ID: 22390866
[Abstract] [Full Text] [Related]
15. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature.
Yanovski JA, Rose SR, Municchi G, Pescovitz OH, Hill SC, Cassorla FG, Cutler GB.
N Engl J Med; 2003 Mar 06; 348(10):908-17. PubMed ID: 12621135
[Abstract] [Full Text] [Related]
16. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F.
J Clin Endocrinol Metab; 1999 Feb 06; 84(2):449-52. PubMed ID: 10022399
[Abstract] [Full Text] [Related]
17. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
Lanes R, Soros A, Jakubowicz S.
J Pediatr Endocrinol Metab; 2004 May 06; 17(5):759-66. PubMed ID: 15237711
[Abstract] [Full Text] [Related]
18. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
Bajpai A, Sharma J, Kabra M, Gupta AK, Menon PS.
Indian Pediatr; 2002 Jul 06; 39(7):633-9. PubMed ID: 12147888
[Abstract] [Full Text] [Related]
19. Precocious puberty and statural growth.
Carel JC, Lahlou N, Roger M, Chaussain JL.
Hum Reprod Update; 2004 Jul 06; 10(2):135-47. PubMed ID: 15073143
[Abstract] [Full Text] [Related]
20. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
Poomthavorn P, Suphasit R, Mahachoklertwattana P.
Gynecol Endocrinol; 2011 Aug 06; 27(8):524-8. PubMed ID: 21501002
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
